Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000921381) titled 'Efficacy of xylometazoline nasal spray in reducing bleeding and nasal symptoms in pateints after septoplasty; A randomized controlled trial' on July 27.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: Rawalpindi Medical University
Condition:
Post-Septoplasty patients
Post-Septoplasty patients
Surgery - Surgical techniques
Respiratory - Other respiratory disorders / diseases
Intervention:
0.1% xylometazoline-hydrochloride nasal spray, one spray per nos...